- About Us
Sarasota, Florida, January 23, 2015 … Roper Industries, Inc. (NYSE: ROP) today announced that it has acquired Strata Decision Technology, L.L.C.
Strata provides the leading cloud-based analytics and performance platform for financial planning, decision support and continuous cost improvement for the healthcare industry. Over 1,000 hospitals, including many of the largest and most influential healthcare delivery systems in the U.S., utilize Strata’s SaaS (software-as-a-service) platform.
“Strata’s applications are critical for healthcare providers in identifying, implementing and sustaining cost improvements,” said Brian Jellison, Chairman and Chief Executive Officer of Roper. “We look forward to working with the Strata team to further accelerate growth and enhance the value they provide to their customers.”
“We believe we have found the best permanent home for Strata,” said Dan Michelson, Chief Executive Officer of Strata. “Roper has a proven track record of helping great technology companies accelerate their growth and build long-term sustainable value for the customers they serve. While I am incredibly proud of our team’s accomplishments in the past, I am even more excited about our future.”
Strata’s management team, led by Dan Michelson, will continue to lead the business from its Chicago headquarters. The company will operate as part of Roper’s Medical segment.
About Roper Industries
Roper Industries is a diversified technology company and is a constituent of the S&P 500, Fortune 1000, and the Russell 1000 indices. Roper provides engineered products and solutions for global niche markets, including software information networks, medical, water, energy, and transportation. Additional information about Roper is available on the company’s website at www.roperind.com.
About Strata Decision Technology
Strata Decision Technology provides an innovative cloud-based financial analytics and performance platform that is used by healthcare providers for financial planning, decision support and continuous cost improvement. Founded in 1996, the company's customer base includes 1,000 hospitals and many of the largest and most influential healthcare delivery systems in the U.S.
The company’s StrataJazz® application is a single integrated software platform that includes modules for capital planning, contract modeling, cost accounting, cost management, decision support, financial forecasting, management reporting, operational budgeting and performance improvement and strategic planning. The company's headquarters are in Chicago, IL. For more information, please visit www.stratadecision.com.
The information provided in this press release contains forward looking statements within the meaning of the federal securities laws. These forward looking statements include, among others, statements regarding operating results, the success of our internal operating plans, and the prospects for newly acquired businesses to be integrated and contribute to future growth and profit expectations. Forward looking statements may be indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "believes" or "intends" and similar words and phrases. These statements reflect management's current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those contained in any forward looking statement. Such risks and uncertainties include our ability to integrate our acquisitions and realize expected synergies. We also face other general risks, including our ability to realize cost savings from our operating initiatives, general economic conditions, unfavorable changes in foreign exchange rates, difficulties associated with exports, risks associated with our international operations, difficulties in making and integrating acquisitions, risks associated with newly acquired businesses, increased product liability and insurance costs, increased warranty exposure, future competition, changes in the supply of, or price for, parts and components, environmental compliance costs and liabilities, risks and cost associated with asbestos related litigation and potential write-offs of our substantial intangible assets, and risks associated with obtaining governmental approvals and maintaining regulatory compliance for new and existing products. Important risks may be discussed in current and subsequent filings with the SEC. You should not place undue reliance on any forward looking statements. These statements speak only as of the date they are made, and we undertake no obligation to update publicly any of them in light of new information or future events.
# # #